The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase

The pyridazine moiety is an important structural feature of various pharmacological active compounds. Synthetic pyridazine compounds have been reported as effective antiprostaglandins (PGs), 5-lipoxygenase (5-LOX), and antiplatelet agents, that is, inhibitors of prostaglandin or cyclooxygenase (COX-...

Full description

Bibliographic Details
Main Author: Mohammad Asif
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2014/703238
id doaj-2fcf265f11e34193a8f4fe60f98b541a
record_format Article
spelling doaj-2fcf265f11e34193a8f4fe60f98b541a2020-11-24T22:55:52ZengHindawi LimitedJournal of Chemistry2090-90632090-90712014-01-01201410.1155/2014/703238703238The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 SynthaseMohammad Asif0Department of Pharmacy, GRD (PG) Institute of Management and Technology, 214 Rajpur Road, Dehradun 248009, IndiaThe pyridazine moiety is an important structural feature of various pharmacological active compounds. Synthetic pyridazine compounds have been reported as effective antiprostaglandins (PGs), 5-lipoxygenase (5-LOX), and antiplatelet agents, that is, inhibitors of prostaglandin or cyclooxygenase (COX-I & COX-II) enzyme, platelet cAMP phosphodiesterase, and thromboxane A2 (TXA2) synthase. These compounds are selective and nonselective COX inhibitors and showed analgesic, anti-inflammatory, and antipyretic activity. Pyridazine compounds with antiplatelet agents inhibited TXA2 enzyme. Pyridazines also exhibited antirheumatoid activity. These pyridazine compounds hold considerable interest relative to the preparation of organic intermediates and other anticipated biologically active compounds.http://dx.doi.org/10.1155/2014/703238
collection DOAJ
language English
format Article
sources DOAJ
author Mohammad Asif
spellingShingle Mohammad Asif
The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase
Journal of Chemistry
author_facet Mohammad Asif
author_sort Mohammad Asif
title The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase
title_short The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase
title_full The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase
title_fullStr The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase
title_full_unstemmed The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase
title_sort study of pyridazine compounds on prostanoids: inhibitors of cox, camp phosphodiesterase, and txa2 synthase
publisher Hindawi Limited
series Journal of Chemistry
issn 2090-9063
2090-9071
publishDate 2014-01-01
description The pyridazine moiety is an important structural feature of various pharmacological active compounds. Synthetic pyridazine compounds have been reported as effective antiprostaglandins (PGs), 5-lipoxygenase (5-LOX), and antiplatelet agents, that is, inhibitors of prostaglandin or cyclooxygenase (COX-I & COX-II) enzyme, platelet cAMP phosphodiesterase, and thromboxane A2 (TXA2) synthase. These compounds are selective and nonselective COX inhibitors and showed analgesic, anti-inflammatory, and antipyretic activity. Pyridazine compounds with antiplatelet agents inhibited TXA2 enzyme. Pyridazines also exhibited antirheumatoid activity. These pyridazine compounds hold considerable interest relative to the preparation of organic intermediates and other anticipated biologically active compounds.
url http://dx.doi.org/10.1155/2014/703238
work_keys_str_mv AT mohammadasif thestudyofpyridazinecompoundsonprostanoidsinhibitorsofcoxcampphosphodiesteraseandtxa2synthase
AT mohammadasif studyofpyridazinecompoundsonprostanoidsinhibitorsofcoxcampphosphodiesteraseandtxa2synthase
_version_ 1725656112979509248